Andrea Harkin

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson et al. · The Lancet Oncology · 2020 · 298 citations

Medicine, Biostatistics, Oncology +13

Association analyses identify 31 new risk loci for colorectal cancer susceptibility

Philip Law, Maria Timofeeva, Ceres Fernández–Rozadilla et al. · Nature Communications · 2019 · 272 citations · Full text

Life Sciences, Genetics, Molecular Genetics +16

Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study

Sophia J. Wagner, Daniel Reisenbüchler, Nicholas P. West et al. · Cancer Cell · 2023 · 247 citations · Full text

Computing, Computer Science, Oncology +17

3 versus 6 months of adjuvant oxaliplatin-fluoropyrimidine combination therapy for colorectal cancer (SCOT): an international, randomised, phase 3, non-inferiority trial

Timothy Iveson, Rachel Kerr, Mark Saunders et al. · The Lancet Oncology · 2018 · 188 citations · Full text

Medicine, Oncology, Pharmacology +16

Duration of Adjuvant Doublet Chemotherapy (3 or 6 months) in Patients With High-Risk Stage II Colorectal Cancer

Timothy Iveson, Alberto Sobrero, Takayuki Yoshino et al. · Journal of Clinical Oncology · 2021 · 104 citations · Full text

Medicine, Pharmacology, Chemotherapy +7